Sushree S. Acharya
Bhubaneshwar, OR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex.
Journal: Expert opinion on therapeutic targets
Published: July 17, 2026
Molecular and therapeutic effects of bioactive compounds-incorporated mucoadhesive buccal patch targeting oral potentially malignant disorders.
Journal: International journal of biological macromolecules
Published: February 15, 2026
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells.
Journal: 3 Biotech
Published: September 03, 2025
Harnessing the immune system: Insights into cancer vaccines.
Journal: Advances in immunology
Published: July 30, 2025
Resveratrol nanoparticles inhibit epithelial-to-mesenchymal transition in oral cancer via p53-independent p21-mediated downregulation of survivin.
Journal: International journal of biological macromolecules
Published: May 31, 2025
Repurposing clonixin and flunixin as anti-fibrotic candidates: Computational and preclinical evaluation in bleomycin-induced pulmonary fibrosis in rats.
Journal: Research in veterinary science
Published: May 16, 2025
Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents.
Journal: Bioorganic chemistry
Published: June 26, 2024
Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21.
Journal: Medical oncology (Northwood, London, England)
Published: March 30, 2024
Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents.
Journal: Journal of biomolecular structure & dynamics
Published: March 04, 2024
Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment.
Journal: Cancer treatment reviews
Published: February 20, 2024
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.
Journal: Medical oncology (Northwood, London, England)
Published: October 16, 2023
Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
Journal: The Journal of nutritional biochemistry
Published: July 31, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026